Ticker LaunchLaw firm
Cooley
Cooley is named in the Legal Matters section of 227 US IPO and 9 SPAC IPO prospectuses tracked by Ticker Launch since 2019, as company counsel on 128 and underwriters' counsel on 108.
US IPOs227
SPAC IPOs9
Deals by year: 2026: 11 · 2025: 13 · 2024: 13 · 2023: 11 · 2022: 4 · 2021: 82 · 2020: 56 · 2019: 46
Deals
| Company | Type | Date | Size | Role |
|---|---|---|---|---|
| City Therapeutics, Inc. | IPO | Oct 16, 2026 | $200M | Underwriters' counsel |
| ADARx Pharmaceuticals, Inc. | IPO | Sep 28, 2026 | $446.2M | Company counsel |
| Electra Therapeutics, Inc. | IPO | Sep 18, 2026 | $350M | Company counsel |
| Latigo Biotherapeutics, Inc. | IPO | Aug 7, 2026 | $345.6M | Company counsel |
| Attovia Therapeutics, Inc. | IPO | Aug 5, 2026 | $289M | Underwriters' counsel |
| Research Alliance Corp IV | SPAC IPO | Jul 13, 2026 | $75M | Company counsel |
| Research Alliance Corp III | SPAC IPO | May 20, 2026 | $75M | Company counsel |
| Odyssey Therapeutics, Inc. | IPO | May 8, 2026 | $279M | Underwriters' counsel |
| HawkEye 360, Inc. | IPO | May 7, 2026 | $416M | Company counsel |
| Veradermics, Inc | IPO | Feb 4, 2026 | $256.3M | Underwriters' counsel |
| Ethos Technologies Inc. | IPO | Jan 30, 2026 | $200M | Company counsel |
| Andersen Group Inc. | IPO | Dec 17, 2025 | $176M | Underwriters' counsel |
| Reed's, Inc. | IPO | Dec 5, 2025 | $10M | Company counsel |
| BillionToOne, Inc. | IPO | Nov 6, 2025 | $273.1M | Underwriters' counsel |
| Evommune, Inc. | IPO | Nov 6, 2025 | $150M | Company counsel |
| Navan, Inc. | IPO | Oct 31, 2025 | — | Company counsel |
| StubHub Holdings, Inc. | IPO | Sep 17, 2025 | $800M | Underwriters' counsel |
| LB Pharmaceuticals Inc | IPO | Sep 12, 2025 | $285M | Company counsel |
| Heartflow, Inc. | IPO | Aug 8, 2025 | — | Underwriters' counsel |
| Shoulder Innovations, Inc. | IPO | Aug 1, 2025 | $75M | Underwriters' counsel |
| Ambiq Micro, Inc. | IPO | Jul 31, 2025 | $96M | Company counsel |
| Caris Life Sciences, Inc. | IPO | Jun 20, 2025 | — | Underwriters' counsel |
| Aardvark Therapeutics, Inc. | IPO | Feb 13, 2025 | $94.2M | Underwriters' counsel |
| Beta Bionics, Inc. | IPO | Jan 31, 2025 | $204M | Company counsel |
| Septerna, Inc. | IPO | Oct 25, 2024 | $288M | Underwriters' counsel |
| Upstream Bio, Inc. | IPO | Oct 11, 2024 | $255M | Underwriters' counsel |
| BioAge Labs, Inc. | IPO | Sep 26, 2024 | $198M | Underwriters' counsel |
| Zenas BioPharma, Inc. | IPO | Sep 13, 2024 | — | Underwriters' counsel |
| Artiva Biotherapeutics, Inc. | IPO | Jul 22, 2024 | $167M | Company counsel |
| Alumis Inc. | IPO | Jun 28, 2024 | — | Company counsel |
| Tempus AI, Inc. | IPO | Jun 17, 2024 | $410.7M | Company counsel |
| Rapport Therapeutics, Inc. | IPO | Jun 7, 2024 | $136M | Underwriters' counsel |
| Silvaco Group, Inc. | IPO | May 10, 2024 | $114M | Underwriters' counsel |
| Rubrik, Inc. | IPO | Apr 26, 2024 | $752M | Company counsel |
| Boundless Bio, Inc. | IPO | Mar 28, 2024 | $100M | Underwriters' counsel |
| Alto Neuroscience, Inc. | IPO | Feb 5, 2024 | $128.6M | Company counsel |
| CG Oncology, Inc. | IPO | Jan 25, 2024 | $380M | Underwriters' counsel |
| CARGO Therapeutics, Inc. | IPO | Nov 13, 2023 | $281.2M | Underwriters' counsel |
| Abivax S.A. | IPO | Oct 23, 2023 | $235.8M | Company counsel |
| Maplebear Inc. | IPO | Sep 20, 2023 | $660M | Company counsel |
| Neumora Therapeutics, Inc. | IPO | Sep 18, 2023 | $250.1M | Underwriters' counsel |
| RayzeBio, Inc. | IPO | Sep 18, 2023 | $311M | Company counsel |
| Turnstone Biologics Corp. | IPO | Jul 24, 2023 | $80M | Company counsel |
| Sagimet Biosciences Inc. | IPO | Jul 17, 2023 | — | Underwriters' counsel |
| Apogee Therapeutics, Inc. | IPO | Jul 17, 2023 | — | Underwriters' counsel |
| ACELYRIN, Inc. | IPO | May 5, 2023 | $540M | Company counsel |
| Structure Therapeutics Inc. | IPO | Feb 6, 2023 | $161.1M | Company counsel |
| GENELUX Corp | IPO | Jan 26, 2023 | $15M | Company counsel |
| Acrivon Therapeutics, Inc. | IPO | Nov 16, 2022 | $94.4M | Company counsel |
| Third Harmonic Bio, Inc. | IPO | Sep 15, 2022 | $185.3M | Underwriters' counsel |
| AN2 Therapeutics, Inc. | IPO | Mar 28, 2022 | $69M | Company counsel |
| CinCor Pharma, Inc. | IPO | Jan 7, 2022 | $193.6M | Company counsel |
| ALSP Orchid Acquisition Corp I | SPAC IPO | Nov 22, 2021 | $150M | Company counsel |
| Sweetgreen, Inc. | IPO | Nov 19, 2021 | $364M | Company counsel |
| Braze, Inc. | IPO | Nov 18, 2021 | $520M | Company counsel |
| Expensify, Inc. | IPO | Nov 12, 2021 | $262.7M | Underwriters' counsel |
| Lulu's Fashion Lounge Holdings, Inc. | IPO | Nov 12, 2021 | $92M | Underwriters' counsel |
| Nerdwallet, Inc. | IPO | Nov 5, 2021 | $130.5M | Company counsel |
| Smartbird, Inc. | IPO | Nov 4, 2021 | $302.9M | Company counsel |
| LianBio | IPO | Nov 2, 2021 | $325M | Underwriters' counsel |
| Aura Biosciences, Inc. | IPO | Nov 1, 2021 | $75.6M | Underwriters' counsel |
| Arteris, Inc. | IPO | Oct 28, 2021 | $70M | Underwriters' counsel |
| Rent the Runway, Inc. | IPO | Oct 27, 2021 | $357M | Underwriters' counsel |
| Xilio Therapeutics, Inc. | IPO | Oct 22, 2021 | $117.6M | Underwriters' counsel |
| Ventyx Biosciences, Inc. | IPO | Oct 21, 2021 | $151.6M | Underwriters' counsel |
| AvidXchange Holdings, Inc. | IPO | Oct 14, 2021 | $660M | Underwriters' counsel |
| Exscientia plc | IPO | Oct 4, 2021 | — | Company counsel |
| Cue Health Inc. | IPO | Sep 27, 2021 | — | Underwriters' counsel |
| Freshworks Inc. | IPO | Sep 22, 2021 | $1.03B | Company counsel |
| DICE Therapeutics, Inc. | IPO | Sep 16, 2021 | $204M | Underwriters' counsel |
| Dutch Bros Inc. | IPO | Sep 16, 2021 | $484.2M | Company counsel |
| PROCEPT BioRobotics Corp | IPO | Sep 16, 2021 | $163.9M | Underwriters' counsel |
| TPB Acquisition Corporation I | SPAC IPO | Aug 12, 2021 | $175M | Company counsel |
| Climb Bio, Inc. | IPO | Aug 11, 2021 | $80M | Company counsel |
| Invivyd, Inc. | IPO | Aug 6, 2021 | $309.4M | Company counsel |
| Gladstone Acquisition Corp | SPAC IPO | Aug 6, 2021 | $100M | Company counsel |
| Rani Therapeutics Holdings, Inc. | IPO | Aug 2, 2021 | $73.3M | Company counsel |
| Maxcyte, Inc. | IPO | Jul 30, 2021 | — | Company counsel |
| Instructure Holdings, Inc. | IPO | Jul 23, 2021 | $250M | Underwriters' counsel |
| Cytek Biosciences, Inc. | IPO | Jul 23, 2021 | $247.6M | Company counsel |
| SOPHiA GENETICS SA | IPO | Jul 23, 2021 | $234M | Underwriters' counsel |
| CS Disco, Inc. | IPO | Jul 22, 2021 | $224M | Company counsel |
| Erasca, Inc. | IPO | Jul 16, 2021 | $300M | Underwriters' counsel |
| CleanTech Acquisition Corp. | SPAC IPO | Jul 16, 2021 | $150M | Underwriters' counsel |
| Acumen Pharmaceuticals, Inc. | IPO | Jul 2, 2021 | $160M | Company counsel |
| Xometry, Inc. | IPO | Jul 1, 2021 | $302.5M | Company counsel |
| Legalzoom.com, Inc. | IPO | Jun 30, 2021 | $535.4M | Company counsel |
| GH Research PLC | IPO | Jun 28, 2021 | — | Underwriters' counsel |
| LENZ Therapeutics, Inc. | IPO | Jun 28, 2021 | $238M | Underwriters' counsel |
| Doximity, Inc. | IPO | Jun 25, 2021 | $605.8M | Underwriters' counsel |
| Ambrx Biopharma Cayman, Inc. | IPO | Jun 21, 2021 | $126M | Company counsel |
| Lyell Immunopharma, Inc. | IPO | Jun 21, 2021 | $425M | Company counsel |
| Verve Therapeutics, Inc. | IPO | Jun 17, 2021 | $266.7M | Underwriters' counsel |
| Molecular Partners AG | IPO | Jun 16, 2021 | $63.8M | Company counsel |
| Janux Therapeutics, Inc. | IPO | Jun 11, 2021 | $193.8M | Company counsel |
| Centessa Pharmaceuticals plc | IPO | Jun 1, 2021 | $330M | Underwriters' counsel |
| FIGS, Inc. | IPO | May 28, 2021 | $580.5M | Underwriters' counsel |
| Singular Genomics Systems, Inc. | IPO | May 28, 2021 | $224.4M | Underwriters' counsel |
| Day One Biopharmaceuticals, Inc. | IPO | May 27, 2021 | $160M | Underwriters' counsel |
| Procore Technologies, Inc. | IPO | May 21, 2021 | $634.5M | Company counsel |
| Vera Therapeutics, Inc. | IPO | May 17, 2021 | $47.9M | Company counsel |
| Similarweb Ltd. | IPO | May 12, 2021 | $176M | Company counsel |
| Valneva SE | IPO | May 7, 2021 | $93.5M | Company counsel |
| Honest Company, Inc. | IPO | May 6, 2021 | $412.9M | Company counsel |
| Werewolf Therapeutics, Inc. | IPO | Apr 30, 2021 | $120M | Underwriters' counsel |
| Treace Medical Concepts, Inc. | IPO | Apr 26, 2021 | $191.2M | Underwriters' counsel |
| UiPath, Inc. | IPO | Apr 21, 2021 | $1.34B | Company counsel |
| Biomea Fusion, Inc. | IPO | Apr 19, 2021 | $153M | Underwriters' counsel |
| VectivBio Holding AG | IPO | Apr 9, 2021 | $127.5M | Company counsel |
| OnKure Therapeutics, Inc. | IPO | Apr 9, 2021 | $93.8M | Company counsel |
| Smart Share Global Ltd | IPO | Apr 2, 2021 | — | Underwriters' counsel |
| Design Therapeutics, Inc. | IPO | Mar 26, 2021 | $240M | Company counsel |
| Edgewise Therapeutics, Inc. | IPO | Mar 26, 2021 | — | Underwriters' counsel |
| Olink Holding AB (publ) | IPO | Mar 26, 2021 | — | Underwriters' counsel |
| ACV Auctions Inc. | IPO | Mar 24, 2021 | $413.8M | Company counsel |
| DigitalOcean Holdings, Inc. | IPO | Mar 24, 2021 | $775.5M | Company counsel |
| Finch Therapeutics Group, Inc. | IPO | Mar 22, 2021 | $127.5M | Company counsel |
| Instil Bio, Inc. | IPO | Mar 22, 2021 | $320M | Company counsel |
| Olo Inc. | IPO | Mar 18, 2021 | $450M | Company counsel |
| Longboard Pharmaceuticals, Inc. | IPO | Mar 12, 2021 | $80M | Company counsel |
| Coupang, Inc. | IPO | Mar 11, 2021 | $4.55B | Company counsel |
| Arrowroot Acquisition Corp. | SPAC IPO | Mar 3, 2021 | $250M | Company counsel |
| DHC Acquisition Corp. | SPAC IPO | Mar 3, 2021 | $300M | Company counsel |
| NexImmune, Inc. | IPO | Feb 16, 2021 | $110M | Underwriters' counsel |
| Talis Biomedical Corp | IPO | Feb 12, 2021 | $220.8M | Company counsel |
| Immunocore Holdings plc | IPO | Feb 8, 2021 | — | Company counsel |
| Lucira Health, Inc. | IPO | Feb 8, 2021 | $153M | Company counsel |
| Vor Biopharma Inc. | IPO | Feb 8, 2021 | $176.9M | Company counsel |
| Elicio Therapeutics, Inc. | IPO | Feb 5, 2021 | $80M | Underwriters' counsel |
| Bolt Biotherapeutics, Inc. | IPO | Feb 5, 2021 | $230M | Company counsel |
| Sana Biotechnology, Inc. | IPO | Feb 5, 2021 | $587.5M | Underwriters' counsel |
| Faeth Therapeutics, Inc. | IPO | Feb 4, 2021 | $133M | Company counsel |
| Zevra Therapeutics, Inc. | IPO | Jan 11, 2021 | — | Company counsel |
| Gracell Biotechnologies Inc. | IPO | Jan 8, 2021 | — | Company counsel |
| Pharming Group N.V. | IPO | Dec 23, 2020 | — | Company counsel |
| 908 Devices Inc. | IPO | Dec 18, 2020 | — | Underwriters' counsel |
| ContextLogic Inc. | IPO | Dec 17, 2020 | $1.1B | Underwriters' counsel |
| 4D Molecular Therapeutics, Inc. | IPO | Dec 14, 2020 | $193.2M | Underwriters' counsel |
| AbCellera Biologics Inc. | IPO | Dec 14, 2020 | $483M | Underwriters' counsel |
| C3.ai, Inc. | IPO | Dec 9, 2020 | $651M | Company counsel |
| ARS Pharmaceuticals, Inc. | IPO | Dec 4, 2020 | $241.5M | Company counsel |
| Kinnate Biopharma Inc. | IPO | Dec 3, 2020 | — | Underwriters' counsel |
| Root, Inc. | IPO | Oct 29, 2020 | $724.4M | Company counsel |
| Datto Holding Corp. | IPO | Oct 22, 2020 | $594M | Underwriters' counsel |
| Opthea Ltd | IPO | Oct 19, 2020 | — | Company counsel |
| 5:01 Acquisition Corp. | SPAC IPO | Oct 14, 2020 | — | Company counsel |
| FuboTV Inc. | IPO | Oct 9, 2020 | $183M | Underwriters' counsel |
| Kronos Bio, Inc. | IPO | Oct 9, 2020 | $250M | Company counsel |
| Spruce Biosciences, Inc. | IPO | Oct 9, 2020 | $90M | Company counsel |
| Immunome Inc. | IPO | Oct 5, 2020 | — | Company counsel |
| C4 Therapeutics, Inc. | IPO | Oct 2, 2020 | $182.4M | Underwriters' counsel |
| Oncorus, Inc. | IPO | Oct 2, 2020 | $87M | Company counsel |
| Pulmonx Corp | IPO | Oct 1, 2020 | $190M | Company counsel |
| Orphazyme A/S | IPO | Sep 29, 2020 | $83.8M | Company counsel |
| VIA optronics AG | IPO | Sep 28, 2020 | $93.8M | Underwriters' counsel |
| Prelude Therapeutics Inc | IPO | Sep 25, 2020 | $158.2M | Underwriters' counsel |
| Taysha Gene Therapies, Inc. | IPO | Sep 25, 2020 | $157.4M | Company counsel |
| Corsair Gaming, Inc. | IPO | Sep 24, 2020 | $238M | Underwriters' counsel |
| COMPASS Pathways plc | IPO | Sep 21, 2020 | $127.5M | Underwriters' counsel |
| Dyne Therapeutics, Inc. | IPO | Sep 17, 2020 | $232.8M | Underwriters' counsel |
| Metacrine, Inc. | IPO | Sep 16, 2020 | $85M | Company counsel |
| Snowflake Inc. | IPO | Sep 16, 2020 | $3.36B | Company counsel |
| Inhibrx, Inc. | IPO | Aug 19, 2020 | $119M | Underwriters' counsel |
| Acutus Medical, Inc. | IPO | Aug 7, 2020 | $158.8M | Underwriters' counsel |
| Commerce.com, Inc. | IPO | Aug 5, 2020 | $216.5M | Underwriters' counsel |
| Vital Farms, Inc. | IPO | Jul 31, 2020 | $204.7M | Company counsel |
| iTeos Therapeutics, Inc. | IPO | Jul 27, 2020 | $201.1M | Underwriters' counsel |
| Annexon, Inc. | IPO | Jul 24, 2020 | $250.8M | Underwriters' counsel |
| ALX Oncology Holdings Inc | IPO | Jul 17, 2020 | $161.5M | Underwriters' counsel |
| Inventiva S.A. | IPO | Jul 13, 2020 | $107.7M | Company counsel |
| Poseida Therapeutics, Inc. | IPO | Jul 10, 2020 | $224M | Company counsel |
| Accolade, Inc. | IPO | Jul 2, 2020 | — | Company counsel |
| PolyPid Ltd. | IPO | Jun 29, 2020 | $60M | Company counsel |
| Akouos, Inc. | IPO | Jun 26, 2020 | $212.5M | Underwriters' counsel |
| Repare Therapeutics Inc. | IPO | Jun 19, 2020 | $220M | Company counsel |
| Vaxcyte, Inc. | IPO | Jun 15, 2020 | $250M | Company counsel |
| Avidity Biosciences, Inc. | IPO | Jun 12, 2020 | $259.2M | Underwriters' counsel |
| Calliditas Therapeutics AB | IPO | Jun 8, 2020 | — | Underwriters' counsel |
| Legend Biotech Corp | IPO | Jun 8, 2020 | $423.8M | Company counsel |
| Applied Molecular Transport Inc. | IPO | Jun 5, 2020 | $154M | Underwriters' counsel |
| Pliant Therapeutics, Inc. | IPO | Jun 3, 2020 | $144M | Underwriters' counsel |
| ADC Therapeutics SA | IPO | May 18, 2020 | — | Underwriters' counsel |
| Oric Pharmaceuticals, Inc. | IPO | Apr 24, 2020 | $120M | Underwriters' counsel |
| Keros Therapeutics, Inc. | IPO | Apr 8, 2020 | $96M | Company counsel |
| Zentalis Pharmaceuticals, Inc. | IPO | Apr 6, 2020 | $165.2M | Underwriters' counsel |
| Enliven Therapeutics, Inc. | IPO | Mar 12, 2020 | $75.2M | Underwriters' counsel |
| Passage BIO, Inc. | IPO | Feb 28, 2020 | $216M | Underwriters' counsel |
| Schrodinger, Inc. | IPO | Feb 6, 2020 | $202M | Underwriters' counsel |
| 1Life Healthcare Inc | IPO | Feb 3, 2020 | $245M | Company counsel |
| Addex Therapeutics Ltd. | IPO | Jan 28, 2020 | — | Company counsel |
| EHang Holdings Ltd | IPO | Dec 12, 2019 | $40M | Company counsel |
| 89bio, Inc. | IPO | Nov 12, 2019 | $84.9M | Underwriters' counsel |
| Fangdd Network Group Ltd. | IPO | Nov 1, 2019 | $78M | Company counsel |
| Phathom Pharmaceuticals, Inc. | IPO | Oct 28, 2019 | $181.7M | Underwriters' counsel |
| Progyny, Inc. | IPO | Oct 25, 2019 | $130M | Company counsel |
| Innate Pharma SA | IPO | Oct 18, 2019 | — | Company counsel |
| Vir Biotechnology, Inc. | IPO | Oct 11, 2019 | $142.9M | Company counsel |
| Oportun Financial Corp | IPO | Sep 27, 2019 | $93.8M | Company counsel |
| Exagen Inc. | IPO | Sep 20, 2019 | $50.4M | Underwriters' counsel |
| Ping Identity Holding Corp. | IPO | Sep 20, 2019 | $187.5M | Underwriters' counsel |
Showing the latest 200 of 236.
See where Cooley ranks: US IPOs · SPAC IPOs
Track Cooley's next deals
Subscribers get each new filing and pricing the morning after, with alerts and Excel export.